Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-16-005133)

Filing Details

Accession Number:: 0001415889-16-005133
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-03-17 16:05:09
Reporting Period:: 2016-03-15

Filing Date:: 2016-03-17
Accepted Time:: 2016-03-17 16:05:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1412486	Cocrystal Pharma Inc.	COCP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1188834	D Ph Jane Hsiao	4400 Biscayne Boulevard Miami FL 33137		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-03-15	1,235,294	$0.51	3,435,294	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,496,654	Indirect	See Footnote

Footnotes

The securities are owned directly by Hsu Gamma Investment, L.P., of which the reporting person is the general partner. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose